vimarsana.com
Home
Live Updates
Skyscraper 08 - Breaking News
Pages:
Latest Breaking News On - Skyscraper 08 - Page 1 : vimarsana.com
Tiragolumab Plus Atezolizumab and Chemotherapy Offers Survival Benefit Over Chemotherapy Alone in ESCC
Tiragolumab plus atezolizumab and chemotherapy led to significant survival improvements vs chemotherapy in patients with esophageal squamous cell carcinoma.
South korea
Hong kong
Baseline patient
Secondary end points
2024 gastrointestinal cancers symposium
Asco gi
Esophageal squamous cell carcinoma
Skyscraper 08
vimarsana © 2020. All Rights Reserved.